Specialized Training for Physicians Interested in Pediatric BMT and Immunotherapies
This intensive one-year fellowship is designed to prepare physicians for academic careers focused on transplantation and cellular therapy. Our program started in the late 1960’s with Nobel prize winner, E. Donnall Thomas, and his team of transplant physicians and clinical staff, who discovered a way to treat advanced leukemia by eradicating malignant white blood cells in the bone marrow using high doses of chemotherapy and radiation, and then replacing them with healthy donor cells. We now have 60 clinical faculty members at Fred Hutch and the University of Washington who specialize in transplantation and cellular therapy and serve as mentors to trainees from around the world.
Program Overview
The pediatric BMT and Immunotherapy fellowship is an intense, year-long program to prepare pediatric hematology-oncology physicians to become adept in blood and marrow transplantation (BMT) and immunotherapy (IMTX) services.
You will have the opportunity to work with world renowned faculty who are on the cutting edge of novel treatments for malignant and non-malignant diseases. The fellow will rotate through outpatient and inpatient BMT (autologous and allogeneic, long-term follow-up) and IMTX services, and initially function as a primary care provider with increasing levels of patient care responsibility over the course of the year. Approximately 8 months will be devoted to clinical activities with the remaining time available to participate in research projects.
The application system is currently accepting materials for the July 2025 - June 2026 academic year.
Fellowship Director
Monica S. Thakar, M.D.
Professor
Clinical Research Division, Fred Hutch
Medical Director
Pediatric Bone Marrow Transplantation Inpatient Services
Committee Members
K. Scott Baker, M.D., M.S.
Professor
Clinical Research Division, Fred Hutch
Joint Professor
Public Health Sciences Division, Fred Hutch
Medical Director
Pediatric Blood and Marrow Transplantation
Director
Survivorship
Application Instructions
The application system is currently accepting materials for the July 2025 - June 2026 academic year.
- C.V.
- Statement of clinical and research interests
- Personal statement outlining your interests in the fellowship program, career goals, and clinical and research interests
- A diversity, equity, and inclusion statement
- Contact information for at least three professional references (including your hem/onc fellowship director)
- The ideal candidate should have an interest in hematopoietic cell transplantation and/or immunotherapy and must have completed a fellowship in pediatric hematology-oncology.
- Applicants must have a medical doctorate (or foreign equivalent) and be board eligible/certified in General Pediatrics.
- U.S. graduates must be board eligible/certified in Pediatric Hematology/Oncology.
- In order to be eligible for sponsorship for an H-1B visa, graduates of foreign medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE).
We believe that the diversity of our fellows, residents, medical students, staff and faculty is a fundamental element of our ability to ensure that all our patients and families receive the highest-quality care – no matter their race, ethnicity, language, literacy, age, gender, gender identity, sexual orientation, religion, disability or finances. Our objective is to create a community that encourages participation and connection, and that values and includes each individual's unique contribution, in every aspect of our mission and practice.
Questions about the program can be sent to:
Lane McCormick
Administrative Manager